Tailored Implants Made of PVDF


DynaMesh®-PRM mesh implants are specially developed for the transobturatoric suburethral sling operation for the treatment of male stress urinary incontinence in light and medium heavy cases. The unique selvedges of DynaMesh®-PRM ensure a simple and atraumatic thread in and adjustment without irritating the surrounding tissue. The dimensional stable textile structure of polyvinylidene fluoride (PVDF) monofilaments with an outstanding effective porosity guarantees an excellent tissue growing-in.

The surgeon selects the method of surgery and final position of the sling depending on her/his preference and the instruments being used. These instruments are procured separately.

Normally, the mesh implant is inserted through a perineal access. The bulbospongiosus muscle is divided in the midline and the urethral bulb is detached from the fibrous nucleus until the urethral bulb is mobile. The tape is inserted transobturatorically with a tunneler. The central mesh part is fixed to the mobile part of the urethral bulb using sutures. Tension on the tape draws the bulb in a cranial direction in the retrourethral space. When the tape is finally in position, a tunnel is formed with an overholt from the perineal wound to the incision site. The ends of the tape are pulled back and cut off at the level of the wound edges. To prevent the tape being displaced in the first weeks of wound healing, the ends of the tape are loosely tied together using a size 2-0 medium-term absorbable suture.

The user must be familiar with the technique involved in implanting a suburethral sling before fitting a DynaMesh®-PRM.


associated instruments

No curling up with DynaMesh®-PRM
High form stability at defined elasticity

The dynamometry is exactly adjusted to the fields of application. At defined elasticity, they are stable enough to perfectly strengthen the anatomical structures and to shrink minimally only.2)
Especially under tension the high effective porosity persists because the mesh only stretches (in a defined way) lengthwise while width does not change.1) 4)


Product range

DynaMesh®-PRM 04 cm x 03 cm PV330453F1 Unit = 1 EA / BX
DynaMesh®-PRM visible 04 cm x 03 cm PV730453F1 Unit = 1 EA / BX

Literature: Male Urinary Incontinence

Contents 1. Polymer PVDF as Implant Material 2. Product Design – Essential Mesh Parameters 3. DynaMesh® visible Technology 4. Male Urinary Incontinence 1. Polymer PVDF as Implant Material 1. Klinge U, Klosterhalfen B, Ottinger AP, et al (2002) PVDF as a new polymer for the construction of surgical meshes. Biomaterials 23:3487–3493 2. Klink CD, Junge […]


DynaMesh® Catalogue:
Male Urinary Stress

Download as PDF (english)

Instructions for Use
Product DynaMesh®-PRM
Field of application Male Urinary Stress Incontinence
Position suburethral
Access The implant is placed transobturatorically in outside-in technique
Technical Data

material: 100% polyvinylidene fluoride monofilament

tension force 0 kg 2 kg
pore size 1.1 mm x 1.3 mm 1.0 mm x 1.4 mm
effective porosity 59.7 % 61.6 %
width of sling 11 mm 10.5 mm

1) Göretzlehner, U:
PVDF as an implant material in urogynaecology
BIOmaterialien, 2007, German language
2) Klinge, U et al:
Demands and properties of alloplastic implants for the treatment of stress urinary incontinence
Expert review of medical devices, 2007
3) Klinge, U et al:
PVDF as a new polymer for the construction of surgical meshes
Biomaterials, 2002
4) Mühl, T et al:
New objective measurement to characterize the porosity of textile implants
Journal of biomedical materials research. Part B Applied biomaterials, 2007
5) Klosterhalfen, B, Institute of Pathology, Hospital Düren, Junge, K. and Klinge, U., University Hospital Aachen
Comparison of bacterial adherences (2010)
6) Klosterhalfen, B, Instituto de patología, hospital de Düren, Alemania
Foreign Body Reaction (2010)
7) Klink, CD et al.
Comparison of long-term biocompatibility of PVDF and PP meshes.
Journal of Investigative Surgery, 2011
8) Laroche, G et al.
Polyvinylidene Fluoride Monofilament Sutures:
“Can they be used safely for long-term anastomoses in the thoracic aorta?”
International Society of Artifical Organs, 1995







By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.